Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

A London clinic has become the first in Europe to roll out two Alzheimer’s wonder drugs privately after they were rejected ...

Donanemab has been hailed 'a new hope' in the fight against dementia, after research suggested it slowed the memory-robbing illness in its early stages. Now, one London clinic has become the ...

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

The U.S. Food and Drug Administration approved Eisai and Biogen’s application for IV maintenance dosing of lecanemab on January 27. Previously, the label called for biweekly IV dosing. The new ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...